91774-53-7 Usage
Uses
Used in Pharmaceutical Industry:
4-Hydroxy-4-Methyl-Hexahydro-1H-azepine hydrochloride is used as a building block for the synthesis of various medications. Its unique cyclic amine structure allows for the development of new pharmaceutical compounds with potential therapeutic applications.
Used in Agrochemical Production:
4-Hydroxy-4-Methyl-Hexahydro-1H-azepine hydrochloride may also have applications in the production of agrochemicals. Its reactivity and ability to form various organic compounds make it a valuable component in the synthesis of agrochemicals for agricultural use.
Used in Dye Production:
In addition to its pharmaceutical and agrochemical applications, 4-Hydroxy-4-Methyl-Hexahydro-1H-azepine hydrochloride may also be used in the production of dyes. Its ability to form a variety of organic compounds can contribute to the development of new dyes with unique properties and applications.
Safety Considerations:
Due to its high reactivity, 4-Hydroxy-4-Methyl-Hexahydro-1H-azepine hydrochloride can be hazardous if not handled properly. Proper safety measures should be taken during its production, storage, and use to minimize potential risks.
Check Digit Verification of cas no
The CAS Registry Mumber 91774-53-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,1,7,7 and 4 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 91774-53:
(7*9)+(6*1)+(5*7)+(4*7)+(3*4)+(2*5)+(1*3)=157
157 % 10 = 7
So 91774-53-7 is a valid CAS Registry Number.
91774-53-7Relevant academic research and scientific papers
NOVEL COMPOUNDS
-
Page/Page column 55, (2008/06/13)
This invention relates to novel compounds useful in the treatment of diseases associated with TRPV4 channel receptor. More specifically, this invention relates to certain substituted amino -azepines, according to Formula (I). Specifically, the invention is directed to compounds according to Formula (I), wherein: R1 is optionally substituted C3-7cycloalkyl, optionally substituted C3-7cycloalkenyl, optionally substituted Het-C3-7alkyl, optionally substituted Het-C3-7-alkenyl, optionally substituted aryl, optionally substituted heterocycloalkyl, optionally substituted heteroaryl, or optionally substituted indenyl; R2 is H, optionally substituted C1-6alkyl, C3-6cycloalkyl-C0-6alkyl, Ar-C0-6alkyl, or Het-C0-6alkyl; each R3 is independently H, optionally substituted C1-8alkyl, optionally substituted C2-8alkenyl, optionally substituted C2-8alkynyl, Het-C1-6 alkyl, optionally substituted C3-6cycloalkyl, optionally substituted heterocycloalkyl, optionally substituted aryl, or optionally substituted heteroaryl, or optionally substituted C1-C6 alkoxy; R4 is H, or optionally substituted C1-C4 alkyl; R5 is H, optionally substituted C1-8alkyl, optionally substituted C2-8alkenyl, optionally substituted C2-8alkynyl, optionally substituted C3-6cycloalkyl, optionally substituted heterocycloalkyl, optionally substituted aryl, or optionally substituted heteroaryl; R6 is H or C1-6alkyl; and X is SO2, CO, CH2, or CONH, and pharmaceutically acceptable salts, hydrates, solvates and pro-drugs thereof.
